Carregant...
Tumor and Systemic Immunomodulatory Effects of MEK Inhibition
PURPOSE OF REVIEW: Mitogen-activated protein kinase (MAPK) kinase (MEK) is an integral component of the RAS signaling pathway, one of the most frequently mutated pathways in cancer biology. MEK inhibitors were initially developed to directly target oncogenic signaling, but are recognized to have ple...
Guardat en:
| Publicat a: | Curr Oncol Rep |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8028056/ https://ncbi.nlm.nih.gov/pubmed/33547983 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11912-020-01008-4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|